Gilead Is First Splash In HIV Patent Pool; Five Other Firms In Negotiations
This article was originally published in The Pink Sheet Daily
Executive Summary
Gilead's deal with the Medicines Patent Pool limits the developing countries that have access to generics and requires that the drugs be manufactured in India.